Oxidative Stress, Antioxidant Capabilities, and Bioavailability: Ellagic Acid or Urolithins?

Area of Science:

• Biochemistry and Molecular Biology
• Nutritional Science
• Pharmacology

Background:

• Oxidative stress (OS) is a key mechanism in numerous human diseases, often inadequately treated by single-target drugs.
• Natural polyphenols, like ellagitannins (ETs) and ellagic acid (EA), offer multi-target antioxidant properties.
• Urolithins (UROs), metabolites of EA, exhibit significant in vivo antioxidant activity and tissue penetration.

Purpose of the Study:

• To review the pathophysiology of oxidative stress (OS).
• To examine the chemical properties and antioxidant mechanisms of ellagic acid (EA) and urolithins (UROs).
• To discuss the clinical applicability of UROs versus EA and the efficacy of EA-enriched products.

Main Methods:

• Literature review focusing on oxidative stress, polyphenol chemistry, and antioxidant mechanisms.
• Analysis of in vitro and in vivo studies comparing EA and UROs.
• Discussion of metabotype-dependent URO production and its implications.

Main Results:

• While EA and UROs show similar in vitro antioxidant potential, UROs demonstrate superior in vivo tissue distribution.
• Individual metabotypes significantly influence URO production, leading to high variability in efficacy.
• This variability challenges the therapeutic potential of UROs and the direct dietary intake of EA.

Conclusions:

• Urolithins (UROs) are the primary active metabolites responsible for the in vivo benefits of ellagic acid (EA) and related compounds.
• The significant inter-individual variability in URO production limits their direct therapeutic application and the efficacy of EA-based supplements.
• Further research is needed to address URO variability and optimize the use of EA and EA-enriched products for managing OS-related diseases.